China's Fosun, Shanghai Pharma say bid for stake in U.S. drugmaker Arbor: Reuters

A unit of China's Fosun Group and Shanghai Pharmaceuticals Holding Co (601607.SS) are among bidders for a stake in U.S. specialty drugmaker Arbor Pharmaceuticals LLC, the companies said on Monday.

DealsNorth AmericaUSBriefs